An imperfect syllogism: granulocyte colony-stimulating factor mobilization and cardiac regeneration
- PMID: 18402896
- PMCID: PMC3153465
- DOI: 10.1016/j.jacc.2008.01.017
An imperfect syllogism: granulocyte colony-stimulating factor mobilization and cardiac regeneration
Abstract
Despite significant progress in pharmaceuticals and medical technology, heart failure remains a major worldwide problem. Most often, heart failure manifests when myocardium becomes injured, dies, and is replaced by fibrous scar tissue. Until recently, it was thought that the heart had no ability to regenerate injured cardiomyocytes, but in 2001, Orlic et al. (1,2) fundamentally altered our thinking by showing that mobilized or directly applied bone marrow (BM)–derived progenitor cells improved myocardial function after infarction. With this observation, the race was on to find the methods and cells that would provide the greatest benefit for cardiac regeneration (3).
Comment on
-
Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.J Am Coll Cardiol. 2008 Apr 15;51(15):1429-37. doi: 10.1016/j.jacc.2007.11.073. J Am Coll Cardiol. 2008. PMID: 18402895
References
-
- Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–5. - PubMed
-
- Dimmeler S, Zeiher AM. Wanted! The best cell for cardiac regeneration. J Am Coll Cardiol. 2004;44:464–6. - PubMed
-
- Kawamoto A, Tkebuchava T, Yamaguchi J, et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation. 2003;107:461–8. - PubMed
-
- Ott I, Keller U, Knoedler M, et al. Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J. 2005;19:992–4. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
